← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2003Last known activity
Dec 31, 2024
Timeline
1980s
- Jun 1, 1985
ALS Association— Founded
Drugs by trial phase (26 distinct, 17 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (17)
- NCT06527222CollaboratorPhase 2Dec 31, 2024
- NCT05377424CollaboratorPhase 1/Phase 2Jun 21, 2022
- NCT03883581CollaboratorPhase 1/Phase 2Aug 31, 2019
- NCT03127514CollaboratorPhase 2Jun 1, 2017
- NCT02710110CollaboratorEarly Phase 1Apr 1, 2016
- NCT02469896CollaboratorPhase 2Nov 1, 2015
- NCT02450552CollaboratorPhase 2Jun 1, 2015
- NCT01884571CollaboratorPhase 2Oct 1, 2013
- NCT01811355CollaboratorPhase 4May 1, 2013
- NCT01806857CollaboratorPhase 2Apr 1, 2013
- NCT01041222CollaboratorPhase 1Jan 1, 2010
- NCT00818389CollaboratorPhase 2/Phase 3Jan 1, 2009
- NCT00409721CollaboratorPhase 2Mar 1, 2007
- NCT00355576CollaboratorPhase 2Jul 1, 2006
- NCT00812851CollaboratorN/AApr 1, 2005
Details
- Founded
- Washington, DC, US Jun 1, 1985
- Last known activity
- Dec 31, 2024